Purchase this article with an account.
Marcelo Jordão L Silva, Priscila C Ferreira, Rubens C Siqueira, Rodrigo Jorge, Andre Messias, Maria Lourdes Veronese Rodrigues, Rodrigo J Calado, Dimas T Covas, Jayter Silva Paula; Ex vivo evaluation of intravitreal mesenchymal stem cell viability using bioluminescence imaging.. Invest. Ophthalmol. Vis. Sci. 2014;55(13):1370.
Download citation file:
© ARVO (1962-2015); The Authors (2016-present)
Bone marrow-derived mesenchymal stem cells (MSC) therapy is a promising treatment for several degenerative diseases, including retinopathies and glaucoma, however no reproducible method of monitoring these cells into the eye has been established. The aim of this study was to describe a successful bioluminescence imaging (BLI) to detect viable luciferase-expressing MSC into the eye.
Human donors’ MSC in culture were infected with 50ul of luciferase lentiviral vector (3,000 viral particles/cell) prior to intraocular injections. Three eyes of two rabbits were evaluated through BLI after receiving 1x106 luciferase-expressing MSC intravitreally with (E1) or without (E2) D-luciferin (40mg/ml - 300 µL of PBS), via pars plana. D-luciferin (40mg/ml - 300 µL of PBS) without cells was injected in a third eye at beginning (E3) and after one hour in E2.
E1 showed high BLI radiance report and decay in eight hours. After D-luciferin infusion, E2 also displayed high average radiance, with similar decay rate of E1. No signal was observed in E3. Figure 1 show the bioluminescence imaging acquired from the three experimental eyes and the figure 2 show the distribution of total amount of captured photons from the three eyes, using bioluminescence, during the eight hours period.
Identification of cell location and viability is still an important problem regarding the use of MSC for eye diseases. This is maybe the first ex vivo study demonstrating BLI is useful and reliable method to address these issues.
This PDF is available to Subscribers Only